tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Gene Mannheimer, 16 are a BUY (72.73%), 6 are a HOLD (27.27%).
Analyst Gene Mannheimer, currently employed at FREEDOM CAPITAL MARKETS, carries an average stock price target met ratio of 70% that have a potential upside of 18.37% achieved within 149 days. Previously, Gene Mannheimer worked at COLLIERS, TOPEKA.
Gene Mannheimer’s has documented 56 price targets and ratings displayed on 10 stocks. The coverage is on Technology, Healthcare sectors.
Most recent stock forecast was given on NUTX, Nutex Health at 25-Sep-2026.
Analyst best performing recommendations are on TEM (TEMPUS AI).
The best stock recommendation documented was for TEM (TEMPUS AI) at 7/8/2026. The price target of $59 was fulfilled within 1 day with a profit of $1.73 (3.02%) receiving and performance score of 30.21.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 12-Apr-2023
$55
$18.28 (49.78%)
$44
2 years 8 months 4 days ago
(22-Feb-2024)
1/2 (50%)
$13.3 (31.89%)
323
Buy Since 17-Oct-2023
$45
$8.28 (22.55%)
$45
2 years 8 months 26 days ago
(30-Jan-2024)
3/3 (100%)
$8.94 (24.79%)
75
Buy Since 19-Dec-2022
$60
$23.28 (63.40%)
$40
3 years 7 months 29 days ago
(27-Feb-2023)
1/2 (50%)
$24.75 (70.21%)
115
Hold Since 08-Aug-2022
$57
$20.28 (55.23%)
$92
4 years 2 months 18 days ago
(08-Aug-2022)
1/2 (50%)
$4.05 (7.65%)
29
Which stock is Gene Mannheimer most bullish on?
Which stock is Gene Mannheimer most reserved on?
What Year was the first public recommendation made by Gene Mannheimer?
